ArticleOncoTargets and therapy2014

PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis.

Yi-Rong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.